Stockholders' Equity (Details) - Schedule of compensation expense related to our stock-based awards - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2020 |
Mar. 31, 2019 |
Mar. 31, 2020 |
Mar. 31, 2019 |
|
| Schedule of compensation expense related to our stock-based awards [Abstract] | ||||
| Research and Development | $ 929 | $ 1,468 | $ 2,675 | $ 3,027 |
| General and Administrative | 874 | 787 | 2,433 | 2,495 |
| Total | $ 1,803 | $ 2,255 | $ 5,108 | $ 5,522 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|